drugset / Trial / NCT00702741
Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of the present study is to establish the long-term safety of an intra-articular injection of human mesenchymal stem cells (hMSCs) (Chondrogen).
Timeline
- Start
- 2008-06
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesenchymal stem cell | Cell therapy | 5e+07 cells | Other |
| Subject | Mesenchymal stem cell | Cell therapy | 1.5e+08 cells | Other |
Indications
No indication recorded.